← 產業報告目錄
Oxcarbazepine API Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 150報告編號 APO-efd051a9c0
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Oxcarbazepine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxcarbazepine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxcarbazepine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Oxcarbazepine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxcarbazepine API include Amoli Organics, Anuja Healthcare, Archimica, Aurore Life Sciences, Bajaj Healthcare, CTX Life Sciences, DEAFARMA, F.I.S.(Fabbrica Italiana Sintetici) and Glenmark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxcarbazepine API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxcarbazepine API Market by Company
Amoli Organics
Anuja Healthcare
Archimica
Aurore Life Sciences
Bajaj Healthcare
CTX Life Sciences
DEAFARMA
F.I.S.(Fabbrica Italiana Sintetici)
Glenmark
Jubilant Pharma
Lianhetech
MSN Laboratories
POLPHARMA
Taj Pharmaceuticals
Trifarma
VPL Chemicals
Mylan
Hubei Gedian Humanwell
Sihuan Pharm
Suzhou Hengyi Pharmaceutical
Sun Pharm
Zhejiang Jiuzhou Pharmaceutical
Oxcarbazepine API Segment by Type
Medical Grade
Other
Oxcarbazepine API Segment by Application
Tablets
Oral Suspension
Other
Oxcarbazepine API Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxcarbazepine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxcarbazepine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxcarbazepine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxcarbazepine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxcarbazepine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxcarbazepine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oxcarbazepine API Market Size (2021-2032)
2.2.2 Global Oxcarbazepine API Sales (2021-2032)
2.2.3 Global Oxcarbazepine API Market Average Price (2021-2032)
2.3 Oxcarbazepine API by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Medical Grade
2.3.3 Other
2.4 Oxcarbazepine API by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Tablets
2.4.3 Oral Suspension
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Oxcarbazepine API Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Oxcarbazepine API Sales (Tons) of Manufacturers (2021-2026)
3.3 Global Oxcarbazepine API Revenue of Manufacturers (2021-2026)
3.4 Global Oxcarbazepine API Average Price by Manufacturers (2021-2026)
3.5 Global Oxcarbazepine API Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Oxcarbazepine API, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oxcarbazepine API, Product Type & Application
3.8 Global Manufacturers of Oxcarbazepine API, Established Date
3.9 Global Oxcarbazepine API Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Amoli Organics
4.1.1 Amoli Organics Company Information
4.1.2 Amoli Organics Business Overview
4.1.3 Amoli Organics Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Amoli Organics Oxcarbazepine API Product Portfolio
4.1.5 Amoli Organics Recent Developments
4.2 Anuja Healthcare
4.2.1 Anuja Healthcare Company Information
4.2.2 Anuja Healthcare Business Overview
4.2.3 Anuja Healthcare Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Anuja Healthcare Oxcarbazepine API Product Portfolio
4.2.5 Anuja Healthcare Recent Developments
4.3 Archimica
4.3.1 Archimica Company Information
4.3.2 Archimica Business Overview
4.3.3 Archimica Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Archimica Oxcarbazepine API Product Portfolio
4.3.5 Archimica Recent Developments
4.4 Aurore Life Sciences
4.4.1 Aurore Life Sciences Company Information
4.4.2 Aurore Life Sciences Business Overview
4.4.3 Aurore Life Sciences Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Aurore Life Sciences Oxcarbazepine API Product Portfolio
4.4.5 Aurore Life Sciences Recent Developments
4.5 Bajaj Healthcare
4.5.1 Bajaj Healthcare Company Information
4.5.2 Bajaj Healthcare Business Overview
4.5.3 Bajaj Healthcare Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Bajaj Healthcare Oxcarbazepine API Product Portfolio
4.5.5 Bajaj Healthcare Recent Developments
4.6 CTX Life Sciences
4.6.1 CTX Life Sciences Company Information
4.6.2 CTX Life Sciences Business Overview
4.6.3 CTX Life Sciences Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.6.4 CTX Life Sciences Oxcarbazepine API Product Portfolio
4.6.5 CTX Life Sciences Recent Developments
4.7 DEAFARMA
4.7.1 DEAFARMA Company Information
4.7.2 DEAFARMA Business Overview
4.7.3 DEAFARMA Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.7.4 DEAFARMA Oxcarbazepine API Product Portfolio
4.7.5 DEAFARMA Recent Developments
4.8 F.I.S.(Fabbrica Italiana Sintetici)
4.8.1 F.I.S.(Fabbrica Italiana Sintetici) Company Information
4.8.2 F.I.S.(Fabbrica Italiana Sintetici) Business Overview
4.8.3 F.I.S.(Fabbrica Italiana Sintetici) Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.8.4 F.I.S.(Fabbrica Italiana Sintetici) Oxcarbazepine API Product Portfolio
4.8.5 F.I.S.(Fabbrica Italiana Sintetici) Recent Developments
4.9 Glenmark
4.9.1 Glenmark Company Information
4.9.2 Glenmark Business Overview
4.9.3 Glenmark Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Glenmark Oxcarbazepine API Product Portfolio
4.9.5 Glenmark Recent Developments
4.10 Jubilant Pharma
4.10.1 Jubilant Pharma Company Information
4.10.2 Jubilant Pharma Business Overview
4.10.3 Jubilant Pharma Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Jubilant Pharma Oxcarbazepine API Product Portfolio
4.10.5 Jubilant Pharma Recent Developments
4.11 Lianhetech
4.11.1 Lianhetech Company Information
4.11.2 Lianhetech Business Overview
4.11.3 Lianhetech Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Lianhetech Oxcarbazepine API Product Portfolio
4.11.5 Lianhetech Recent Developments
4.12 MSN Laboratories
4.12.1 MSN Laboratories Company Information
4.12.2 MSN Laboratories Business Overview
4.12.3 MSN Laboratories Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.12.4 MSN Laboratories Oxcarbazepine API Product Portfolio
4.12.5 MSN Laboratories Recent Developments
4.13 POLPHARMA
4.13.1 POLPHARMA Company Information
4.13.2 POLPHARMA Business Overview
4.13.3 POLPHARMA Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.13.4 POLPHARMA Oxcarbazepine API Product Portfolio
4.13.5 POLPHARMA Recent Developments
4.14 Taj Pharmaceuticals
4.14.1 Taj Pharmaceuticals Company Information
4.14.2 Taj Pharmaceuticals Business Overview
4.14.3 Taj Pharmaceuticals Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Taj Pharmaceuticals Oxcarbazepine API Product Portfolio
4.14.5 Taj Pharmaceuticals Recent Developments
4.15 Trifarma
4.15.1 Trifarma Company Information
4.15.2 Trifarma Business Overview
4.15.3 Trifarma Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Trifarma Oxcarbazepine API Product Portfolio
4.15.5 Trifarma Recent Developments
4.16 VPL Chemicals
4.16.1 VPL Chemicals Company Information
4.16.2 VPL Chemicals Business Overview
4.16.3 VPL Chemicals Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.16.4 VPL Chemicals Oxcarbazepine API Product Portfolio
4.16.5 VPL Chemicals Recent Developments
4.17 Mylan
4.17.1 Mylan Company Information
4.17.2 Mylan Business Overview
4.17.3 Mylan Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Mylan Oxcarbazepine API Product Portfolio
4.17.5 Mylan Recent Developments
4.18 Hubei Gedian Humanwell
4.18.1 Hubei Gedian Humanwell Company Information
4.18.2 Hubei Gedian Humanwell Business Overview
4.18.3 Hubei Gedian Humanwell Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Hubei Gedian Humanwell Oxcarbazepine API Product Portfolio
4.18.5 Hubei Gedian Humanwell Recent Developments
4.19 Sihuan Pharm
4.19.1 Sihuan Pharm Company Information
4.19.2 Sihuan Pharm Business Overview
4.19.3 Sihuan Pharm Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Sihuan Pharm Oxcarbazepine API Product Portfolio
4.19.5 Sihuan Pharm Recent Developments
4.20 Suzhou Hengyi Pharmaceutical
4.20.1 Suzhou Hengyi Pharmaceutical Company Information
4.20.2 Suzhou Hengyi Pharmaceutical Business Overview
4.20.3 Suzhou Hengyi Pharmaceutical Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.20.4 Suzhou Hengyi Pharmaceutical Oxcarbazepine API Product Portfolio
4.20.5 Suzhou Hengyi Pharmaceutical Recent Developments
4.21 Sun Pharm
4.21.1 Sun Pharm Company Information
4.21.2 Sun Pharm Business Overview
4.21.3 Sun Pharm Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.21.4 Sun Pharm Oxcarbazepine API Product Portfolio
4.21.5 Sun Pharm Recent Developments
4.22 Zhejiang Jiuzhou Pharmaceutical
4.22.1 Zhejiang Jiuzhou Pharmaceutical Company Information
4.22.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
4.22.3 Zhejiang Jiuzhou Pharmaceutical Oxcarbazepine API Sales, Revenue and Gross Margin (2021-2026)
4.22.4 Zhejiang Jiuzhou Pharmaceutical Oxcarbazepine API Product Portfolio
4.22.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
5 Global Oxcarbazepine API Market Scenario by Region
5.1 Global Oxcarbazepine API Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Oxcarbazepine API Sales by Region: 2021-2032
5.2.1 Global Oxcarbazepine API Sales by Region: 2021-2026
5.2.2 Global Oxcarbazepine API Sales by Region: 2027-2032
5.3 Global Oxcarbazepine API Revenue by Region: 2021-2032
5.3.1 Global Oxcarbazepine API Revenue by Region: 2021-2026
5.3.2 Global Oxcarbazepine API Revenue by Region: 2027-2032
5.4 North America Oxcarbazepine API Market Facts & Figures by Country
5.4.1 North America Oxcarbazepine API Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Oxcarbazepine API Sales by Country (2021-2032)
5.4.3 North America Oxcarbazepine API Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Oxcarbazepine API Market Facts & Figures by Country
5.5.1 Europe Oxcarbazepine API Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Oxcarbazepine API Sales by Country (2021-2032)
5.5.3 Europe Oxcarbazepine API Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Oxcarbazepine API Market Facts & Figures by Country
5.6.1 Asia Pacific Oxcarbazepine API Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Oxcarbazepine API Sales by Country (2021-2032)
5.6.3 Asia Pacific Oxcarbazepine API Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Oxcarbazepine API Market Facts & Figures by Country
5.7.1 South America Oxcarbazepine API Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Oxcarbazepine API Sales by Country (2021-2032)
5.7.3 South America Oxcarbazepine API Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oxcarbazepine API Market Facts & Figures by Country
5.8.1 Middle East and Africa Oxcarbazepine API Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Oxcarbazepine API Sales by Country (2021-2032)
5.8.3 Middle East and Africa Oxcarbazepine API Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Oxcarbazepine API Sales by Type (2021-2032)
6.1.1 Global Oxcarbazepine API Sales by Type (2021-2032) & (Tons)
6.1.2 Global Oxcarbazepine API Sales Market Share by Type (2021-2032)
6.2 Global Oxcarbazepine API Revenue by Type (2021-2032)
6.2.1 Global Oxcarbazepine API Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Oxcarbazepine API Revenue Market Share by Type (2021-2032)
6.3 Global Oxcarbazepine API Price by Type (2021-2032)
7 Segment by Application
7.1 Global Oxcarbazepine API Sales by Application (2021-2032)
7.1.1 Global Oxcarbazepine API Sales by Application (2021-2032) & (Tons)
7.1.2 Global Oxcarbazepine API Sales Market Share by Application (2021-2032)
7.2 Global Oxcarbazepine API Revenue by Application (2021-2032)
7.2.1 Global Oxcarbazepine API Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Oxcarbazepine API Revenue Market Share by Application (2021-2032)
7.3 Global Oxcarbazepine API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Oxcarbazepine API Value Chain Analysis
8.1.1 Oxcarbazepine API Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oxcarbazepine API Production Mode & Process
8.2 Oxcarbazepine API Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oxcarbazepine API Distributors
8.2.3 Oxcarbazepine API Customers
9 Global Oxcarbazepine API Analyzing Market Dynamics
9.1 Oxcarbazepine API Industry Trends
9.2 Oxcarbazepine API Industry Drivers
9.3 Oxcarbazepine API Industry Opportunities and Challenges
9.4 Oxcarbazepine API Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Oxcarbazepine API Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Oxcarbazepine API Sales (Tons) of Manufacturers (2021-2026)
Table 7. Global Oxcarbazepine API Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Oxcarbazepine API Revenue of Manufacturers (2021-2026)
Table 9. Global Oxcarbazepine API Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Oxcarbazepine API Average Price (US$/Ton) of Manufacturers (2021-2026)
Table 11. Global Oxcarbazepine API Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Oxcarbazepine API, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Oxcarbazepine API, Product Type & Application
Table 14. Global Oxcarbazepine API Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Oxcarbazepine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Amoli Organics Company Information
Table 19. Amoli Organics Business Overview
Table 20. Amoli Organics Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 21. Amoli Organics Oxcarbazepine API Product Portfolio
Table 22. Amoli Organics Recent Developments
Table 23. Anuja Healthcare Company Information
Table 24. Anuja Healthcare Business Overview
Table 25. Anuja Healthcare Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 26. Anuja Healthcare Oxcarbazepine API Product Portfolio
Table 27. Anuja Healthcare Recent Developments
Table 28. Archimica Company Information
Table 29. Archimica Business Overview
Table 30. Archimica Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 31. Archimica Oxcarbazepine API Product Portfolio
Table 32. Archimica Recent Developments
Table 33. Aurore Life Sciences Company Information
Table 34. Aurore Life Sciences Business Overview
Table 35. Aurore Life Sciences Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 36. Aurore Life Sciences Oxcarbazepine API Product Portfolio
Table 37. Aurore Life Sciences Recent Developments
Table 38. Bajaj Healthcare Company Information
Table 39. Bajaj Healthcare Business Overview
Table 40. Bajaj Healthcare Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 41. Bajaj Healthcare Oxcarbazepine API Product Portfolio
Table 42. Bajaj Healthcare Recent Developments
Table 43. CTX Life Sciences Company Information
Table 44. CTX Life Sciences Business Overview
Table 45. CTX Life Sciences Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 46. CTX Life Sciences Oxcarbazepine API Product Portfolio
Table 47. CTX Life Sciences Recent Developments
Table 48. DEAFARMA Company Information
Table 49. DEAFARMA Business Overview
Table 50. DEAFARMA Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 51. DEAFARMA Oxcarbazepine API Product Portfolio
Table 52. DEAFARMA Recent Developments
Table 53. F.I.S.(Fabbrica Italiana Sintetici) Company Information
Table 54. F.I.S.(Fabbrica Italiana Sintetici) Business Overview
Table 55. F.I.S.(Fabbrica Italiana Sintetici) Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 56. F.I.S.(Fabbrica Italiana Sintetici) Oxcarbazepine API Product Portfolio
Table 57. F.I.S.(Fabbrica Italiana Sintetici) Recent Developments
Table 58. Glenmark Company Information
Table 59. Glenmark Business Overview
Table 60. Glenmark Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 61. Glenmark Oxcarbazepine API Product Portfolio
Table 62. Glenmark Recent Developments
Table 63. Jubilant Pharma Company Information
Table 64. Jubilant Pharma Business Overview
Table 65. Jubilant Pharma Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 66. Jubilant Pharma Oxcarbazepine API Product Portfolio
Table 67. Jubilant Pharma Recent Developments
Table 68. Lianhetech Company Information
Table 69. Lianhetech Business Overview
Table 70. Lianhetech Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 71. Lianhetech Oxcarbazepine API Product Portfolio
Table 72. Lianhetech Recent Developments
Table 73. MSN Laboratories Company Information
Table 74. MSN Laboratories Business Overview
Table 75. MSN Laboratories Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 76. MSN Laboratories Oxcarbazepine API Product Portfolio
Table 77. MSN Laboratories Recent Developments
Table 78. POLPHARMA Company Information
Table 79. POLPHARMA Business Overview
Table 80. POLPHARMA Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 81. POLPHARMA Oxcarbazepine API Product Portfolio
Table 82. POLPHARMA Recent Developments
Table 83. Taj Pharmaceuticals Company Information
Table 84. Taj Pharmaceuticals Business Overview
Table 85. Taj Pharmaceuticals Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 86. Taj Pharmaceuticals Oxcarbazepine API Product Portfolio
Table 87. Taj Pharmaceuticals Recent Developments
Table 88. Trifarma Company Information
Table 89. Trifarma Business Overview
Table 90. Trifarma Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. Trifarma Oxcarbazepine API Product Portfolio
Table 92. Trifarma Recent Developments
Table 93. VPL Chemicals Company Information
Table 94. VPL Chemicals Business Overview
Table 95. VPL Chemicals Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. VPL Chemicals Oxcarbazepine API Product Portfolio
Table 97. VPL Chemicals Recent Developments
Table 98. Mylan Company Information
Table 99. Mylan Business Overview
Table 100. Mylan Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Mylan Oxcarbazepine API Product Portfolio
Table 102. Mylan Recent Developments
Table 103. Hubei Gedian Humanwell Company Information
Table 104. Hubei Gedian Humanwell Business Overview
Table 105. Hubei Gedian Humanwell Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Hubei Gedian Humanwell Oxcarbazepine API Product Portfolio
Table 107. Hubei Gedian Humanwell Recent Developments
Table 108. Sihuan Pharm Company Information
Table 109. Sihuan Pharm Business Overview
Table 110. Sihuan Pharm Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. Sihuan Pharm Oxcarbazepine API Product Portfolio
Table 112. Sihuan Pharm Recent Developments
Table 113. Suzhou Hengyi Pharmaceutical Company Information
Table 114. Suzhou Hengyi Pharmaceutical Business Overview
Table 115. Suzhou Hengyi Pharmaceutical Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 116. Suzhou Hengyi Pharmaceutical Oxcarbazepine API Product Portfolio
Table 117. Suzhou Hengyi Pharmaceutical Recent Developments
Table 118. Sun Pharm Company Information
Table 119. Sun Pharm Business Overview
Table 120. Sun Pharm Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 121. Sun Pharm Oxcarbazepine API Product Portfolio
Table 122. Sun Pharm Recent Developments
Table 123. Zhejiang Jiuzhou Pharmaceutical Company Information
Table 124. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 125. Zhejiang Jiuzhou Pharmaceutical Oxcarbazepine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 126. Zhejiang Jiuzhou Pharmaceutical Oxcarbazepine API Product Portfolio
Table 127. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 128. Global Oxcarbazepine API Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 129. Global Oxcarbazepine API Sales by Region (2021-2026) & (Tons)
Table 130. Global Oxcarbazepine API Sales Market Share by Region (2021-2026)
Table 131. Global Oxcarbazepine API Sales by Region (2027-2032) & (Tons)
Table 132. Global Oxcarbazepine API Sales Market Share by Region (2027-2032)
Table 133. Global Oxcarbazepine API Revenue by Region (2021-2026) & (US$ Million)
Table 134. Global Oxcarbazepine API Revenue Market Share by Region (2021-2026)
Table 135. Global Oxcarbazepine API Revenue by Region (2027-2032) & (US$ Million)
Table 136. Global Oxcarbazepine API Revenue Market Share by Region (2027-2032)
Table 137. North America Oxcarbazepine API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. North America Oxcarbazepine API Sales by Country (2021-2026) & (Tons)
Table 139. North America Oxcarbazepine API Sales by Country (2027-2032) & (Tons)
Table 140. North America Oxcarbazepine API Revenue by Country (2021-2026) & (US$ Million)
Table 141. North America Oxcarbazepine API Revenue by Country (2027-2032) & (US$ Million)
Table 142. Europe Oxcarbazepine API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Europe Oxcarbazepine API Sales by Country (2021-2026) & (Tons)
Table 144. Europe Oxcarbazepine API Sales by Country (2027-2032) & (Tons)
Table 145. Europe Oxcarbazepine API Revenue by Country (2021-2026) & (US$ Million)
Table 146. Europe Oxcarbazepine API Revenue by Country (2027-2032) & (US$ Million)
Table 147. Asia Pacific Oxcarbazepine API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. Asia Pacific Oxcarbazepine API Sales by Country (2021-2026) & (Tons)
Table 149. Asia Pacific Oxcarbazepine API Sales by Country (2027-2032) & (Tons)
Table 150. Asia Pacific Oxcarbazepine API Revenue by Country (2021-2026) & (US$ Million)
Table 151. Asia Pacific Oxcarbazepine API Revenue by Country (2027-2032) & (US$ Million)
Table 152. South America Oxcarbazepine API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. South America Oxcarbazepine API Sales by Country (2021-2026) & (Tons)
Table 154. South America Oxcarbazepine API Sales by Country (2027-2032) & (Tons)
Table 155. South America Oxcarbazepine API Revenue by Country (2021-2026) & (US$ Million)
Table 156. South America Oxcarbazepine API Revenue by Country (2027-2032) & (US$ Million)
Table 157. Middle East and Africa Oxcarbazepine API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 158. Middle East and Africa Oxcarbazepine API Sales by Country (2021-2026) & (Tons)
Table 159. Middle East and Africa Oxcarbazepine API Sales by Country (2027-2032) & (Tons)
Table 160. Middle East and Africa Oxcarbazepine API Revenue by Country (2021-2026) & (US$ Million)
Table 161. Middle East and Africa Oxcarbazepine API Revenue by Country (2027-2032) & (US$ Million)
Table 162. Global Oxcarbazepine API Sales by Type (2021-2026) & (Tons)
Table 163. Global Oxcarbazepine API Sales by Type (2027-2032) & (Tons)
Table 164. Global Oxcarbazepine API Sales Market Share by Type (2021-2026)
Table 165. Global Oxcarbazepine API Sales Market Share by Type (2027-2032)
Table 166. Global Oxcarbazepine API Revenue by Type (2021-2026) & (US$ Million)
Table 167. Global Oxcarbazepine API Revenue by Type (2027-2032) & (US$ Million)
Table 168. Global Oxcarbazepine API Revenue Market Share by Type (2021-2026)
Table 169. Global Oxcarbazepine API Revenue Market Share by Type (2027-2032)
Table 170. Global Oxcarbazepine API Price by Type (2021-2026) & (US$/Ton)
Table 171. Global Oxcarbazepine API Price by Type (2027-2032) & (US$/Ton)
Table 172. Global Oxcarbazepine API Sales by Application (2021-2026) & (Tons)
Table 173. Global Oxcarbazepine API Sales by Application (2027-2032) & (Tons)
Table 174. Global Oxcarbazepine API Sales Market Share by Application (2021-2026)
Table 175. Global Oxcarbazepine API Sales Market Share by Application (2027-2032)
Table 176. Global Oxcarbazepine API Revenue by Application (2021-2026) & (US$ Million)
Table 177. Global Oxcarbazepine API Revenue by Application (2027-2032) & (US$ Million)
Table 178. Global Oxcarbazepine API Revenue Market Share by Application (2021-2026)
Table 179. Global Oxcarbazepine API Revenue Market Share by Application (2027-2032)
Table 180. Global Oxcarbazepine API Price by Application (2021-2026) & (US$/Ton)
Table 181. Global Oxcarbazepine API Price by Application (2027-2032) & (US$/Ton)
Table 182. Key Raw Materials
Table 183. Raw Materials Key Suppliers
Table 184. Oxcarbazepine API Distributors List
Table 185. Oxcarbazepine API Customers List
Table 186. Oxcarbazepine API Industry Trends
Table 187. Oxcarbazepine API Industry Drivers
Table 188. Oxcarbazepine API Industry Restraints
Table 189. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Oxcarbazepine API Product Image
Figure 5. Global Oxcarbazepine API Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Oxcarbazepine API Market Size (2021-2032) & (US$ Million)
Figure 7. Global Oxcarbazepine API Sales (2021-2032) & (Tons)
Figure 8. Global Oxcarbazepine API Average Price (US$/Ton) & (2021-2032)
Figure 9. Medical Grade Product Image
Figure 10. Other Product Image
Figure 11. Tablets Product Image
Figure 12. Oral Suspension Product Image
Figure 13. Other Product Image
Figure 14. Global Oxcarbazepine API Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Oxcarbazepine API, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Oxcarbazepine API Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Oxcarbazepine API Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Oxcarbazepine API Sales by Region in 2025
Figure 20. Global Oxcarbazepine API Revenue by Region in 2025
Figure 21. North America Oxcarbazepine API Market Size by Country in 2025
Figure 22. North America Oxcarbazepine API Sales Market Share by Country (2021-2032)
Figure 23. North America Oxcarbazepine API Revenue Market Share by Country (2021-2032)
Figure 24. United States Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Oxcarbazepine API Market Size by Country in 2025
Figure 27. Europe Oxcarbazepine API Sales Market Share by Country (2021-2032)
Figure 28. Europe Oxcarbazepine API Revenue Market Share by Country (2021-2032)
Figure 29. Germany Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Netherlands Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Nordic Countries Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Oxcarbazepine API Market Size by Country in 2025
Figure 36. Asia Pacific Oxcarbazepine API Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Oxcarbazepine API Revenue Market Share by Country (2021-2032)
Figure 38. China Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Oxcarbazepine API Market Size by Country in 2025
Figure 47. South America Oxcarbazepine API Sales Market Share by Country (2021-2032)
Figure 48. South America Oxcarbazepine API Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Middle East and Africa Oxcarbazepine API Market Size by Country in 2025
Figure 53. Middle East and Africa Oxcarbazepine API Sales Market Share by Country (2021-2032)
Figure 54. Middle East and Africa Oxcarbazepine API Revenue Market Share by Country (2021-2032)
Figure 55. Turkey Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Saudi Arabia Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. UAE Oxcarbazepine API Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Global Oxcarbazepine API Sales Market Share by Type (2021-2032)
Figure 59. Global Oxcarbazepine API Revenue Market Share by Type (2021-2032)
Figure 60. Global Oxcarbazepine API Price (US$/Ton) by Type (2021-2032)
Figure 61. Global Oxcarbazepine API Sales Market Share by Application (2021-2032)
Figure 62. Global Oxcarbazepine API Revenue Market Share by Application (2021-2032)
Figure 63. Global Oxcarbazepine API Price (US$/Ton) by Application (2021-2032)
Figure 64. Oxcarbazepine API Value Chain
Figure 65. Oxcarbazepine API Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Oxcarbazepine API Industry Opportunities and Challenges
提及公司
Amoli OrganicsAnuja HealthcareArchimicaAurore Life SciencesBajaj HealthcareCTX Life SciencesDEAFARMAF.I.S.(Fabbrica Italiana Sintetici)GlenmarkJubilant PharmaLianhetechMSN LaboratoriesPOLPHARMATaj PharmaceuticalsTrifarmaVPL ChemicalsMylanHubei Gedian HumanwellSihuan PharmSuzhou Hengyi PharmaceuticalSun PharmZhejiang Jiuzhou Pharmaceutical
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們